Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06996639 · ClinicalTrials.gov registry record · NA
Breaking Fasts Ahead of Cardiac Caths
A NA study of NSTEMI - Non-ST Segment Elevation MI and Stable Angina (SA), sponsored by University of South Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06996639: Recruiting NA study of NSTEMI - Non-ST Segment Elevation MI and Stable Angina (SA), sponsored by University of South Florida.
NCT06996639 is a NA study of NSTEMI - Non-ST Segment Elevation MI and Stable Angina (SA) that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 400 participants, below the 16,328-participant average among 4 other NSTEMI - Non-ST Segment Elevation MI trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06996639, a NA study of NSTEMI - Non-ST Segment Elevation MI and Stable Angina (SA), is actively recruiting participants, sponsored by University of South Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to find out whether fasting is necessary before urgent inpatient cardiac catheterizations. For patients presenting with urgent heart-related pain or even mild heart attacks, researchers want to know whether eating and drinking before their procedure improves comfort without raising the risk of complications. The study will answer: * Does eating and drinking before the procedure improve patient comfort? * Does it increase the risk of adverse events like vomiting, aspiration (food or liquid entering the lungs), breathing problems, or death, etc? Participants will be randomly assigned to either: * A standard fasting group (no food for 6 hours, no clear liquids for 2 hours), or * A no-fasting group (able to eat and drink as usual). Patients will complete brief surveys before the procedure to assess comfort and satisfaction. Researchers will also review medical records weekly and 30 days later to monitor for safety outcomes.
Primary Outcome
Patient satisfaction and comfort will be assessed using a six-item survey evaluating hunger, thirst, nausea, nervousness, anger, and weakness. Each item is rated on a 5-point Likert scale from 1 ("strongly disagree" = least discomfort) to 5 ("strongly agree" = most discomfort). The total score ranges from 6 (best possible comfort) to 30 (worst possible discomfort). Higher scores indicate greater overall discomfort.
Conditions Studied
Interventions
- BEHAVIORAL Fasting
- BEHAVIORAL Non-Fasting
Study Locations (1)
Florida
- Tampa General Hospital - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-10-13 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT06996639 shows while recruiting
NCT06996639 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 16,328-participant average among 4 other NSTEMI - Non-ST Segment Elevation MI trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with NSTEMI - Non-ST Segment Elevation MI appearing as the primary indexed condition, and to 2 interventions - of which Fasting is the first listed.
NCT06996639 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06996639 about?
NCT06996639 is a clinical study titled "Breaking Fasts Ahead of Cardiac Caths". The goal of this clinical trial is to find out whether fasting is necessary before urgent inpatient cardiac catheterizations. For patients presenting with urgent heart-related pain or even mild heart attacks, researchers want to know whether eating and drinking before their procedure improves comfor...
What is the current status of trial NCT06996639?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-10-13. Estimated completion is 2026-07.
What conditions does trial NCT06996639 study?
This clinical trial studies the following conditions: NSTEMI - Non-ST Segment Elevation MI, Stable Angina (SA), Unstable Angina (UA).
What interventions are being tested in trial NCT06996639?
The interventions under investigation include: Fasting (BEHAVIORAL), Non-Fasting (BEHAVIORAL).
Who is sponsoring clinical trial NCT06996639?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06996639 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NSTEMI - Non-ST Segment Elevation MI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI